Accutane Scripts Would Be Limited To Approved Indication Under House Bill
Executive Summary
Prescriptions for Roche's Accutane would be limited to the acne drug's approved indication under legislation introduced June 16 by Reps. Bart Stupak (D-Mich.) and Chris Smith (R-N.J.)
You may also be interested in...
Allergan Tazoral Turned Down By FDA Cmte.: Off-Label Acne Use Is Concern
Concerns about potential off-label use of Allergan's Tazoral as acne therapy figured heavily in an FDA advisory committee's recommendation against approving the retinoid drug for the treatment of moderate to severe psoriasis
Allergan Tazoral Turned Down By FDA Cmte.: Off-Label Acne Use Is Concern
Concerns about potential off-label use of Allergan's Tazoral as acne therapy figured heavily in an FDA advisory committee's recommendation against approving the retinoid drug for the treatment of moderate to severe psoriasis
Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
Rep. Bart Stupak (D-Mich.) is drafting legislation to mandate patient and prescriber registries for the acne drug Accutane